However, there is a problem facing the treatment of osteoporosis, and it is the lack of research into new therapies, leading to a limited pipeline of new treatments coming through. In the UK ...

the efficacy data do not clearly show that PTH should be selected over antiresorptive therapies for the treatment of osteoporosis. In addition, PTH is expensive and must be administered daily via ...

Bone health experts are urging Filipinos, especially those aged 50 and above, and their families, to prioritize osteoporosis ...

The Philippine Orthopaedic Association (POA) marked a milestone with its 75th Annual Congress held from Nov. 13 to 16, 2024 ...

500 healthcare professionals, 11 chairpersons, and 15 distinguished speakers for in-depth discussions on advancements in ...

Two Key Genes Identified Linking Rheumatoid Arthritis and Osteoporosis Nov ... serve as diagnostic tools and potential targets for treatments. Drawing from a large database of ...

New analysis presented by the company, together with an improved discount to the price of vamorolone, mean that NICE can now ...

As bones age, they may weaken or grow abnormally. Osteoporosis and Paget's disease, though different, both affect bone health ...

The new Quality Statement for Osteoporosis and Bone Health provides a framework for the delivery of care, including ...

The new Quality Statement for Osteoporosis and Bone Health provides a framework for the delivery of care, including ...

Our Future Health, the UK’s largest health research programme, is offering appointments in six new locations in December 2024, with 210 clinics in total across the UK.